Repare Therapeutics Inc.
(RPTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -93.80M | -29.05M | -106.91M | -53.42M | -27.22M | -14.28M | -7.80M |
| Depreciation & Amortization | 1.95M | 1.98M | 1.47M | 897.00K | 605.00K | 407.00K | 102.00K |
| Stock-Based Compensation | 25.06M | 19.69M | 12.83M | 2.54M | 511.00K | 306.00K | 34.00K |
| Other Working Capital | -57.12M | 10.90M | 4.64M | 42.40M | 5.75M | -494.00K | -491.00K |
| Other Non-Cash Items | -5.19M | -3.94M | 1.87M | 890.00K | 1.71M | 1.13M | 1.43M |
| Deferred Income Tax | - | 3.62M | 149.00K | 588.00K | -629.00K | 306.00K | -11.00K |
| Change in Working Capital | -55.18M | 8.03M | 4.79M | 42.42M | 6.59M | -484.00K | 239.00K |
| Operating Cash Flow | -127.16M | 322.00K | -85.80M | -6.08M | -18.43M | -12.62M | -6.01M |
| Capital Expenditures | -1.94M | -602.00K | -1.69M | -2.24M | -1.30M | -583.00K | -1.16M |
| Acquisitions | - | 175.18M | 40.00K | - | - | - | - |
| Purchase of Investments | -179.02M | -256.58M | -7.48M | -7.53M | - | - | - |
| Sales Maturities Of Investments | 259.00M | 81.40M | 7.45M | - | - | - | - |
| Other Investing Acitivies | - | -175.18M | 14.00K | -7.53M | - | - | - |
| Investing Cash Flow | 78.04M | -175.78M | -1.68M | -9.76M | -1.30M | -583.00K | -1.16M |
| Debt Repayment | - | - | - | - | - | - | 1.50M |
| Common Stock Repurchased | 689.00K | 433.00K | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 842.00K | 880.00K | 1.27M | 15.80M | 103.24M | - | 28.96M |
| Financial Cash Flow | 842.00K | 880.00K | 95.56M | 247.84M | 103.24M | - | 30.46M |
| Net Cash Flow | -48.25M | -174.91M | 8.03M | 231.39M | 84.08M | -13.46M | 23.30M |
| Free Cash Flow | -129.10M | -280.00K | -87.49M | -8.32M | -19.73M | -13.20M | -7.16M |